Extens sells its stake in Discngine

Back Published on 23/12/2022

Extens announces the sale of its stake in Discngine to the Canadian Chemical Computing Group (CCG) after five years of successful collaboration.

Discngine, provides modelling software solutions for the pharmaceutical and life sciences sector to accelerate molecular research thanks to high-performance data acquisition and analysis tools. Discngine is a recognised expert in its field, with customers including some of the world's leading laboratories, and has established partnerships with leading software vendors to integrate its technology into global offerings.